Individuals with severe GI conditions Gastroparesis, severe inflammatory bowel disease, and other conditions affecting GI motility could be worsened by a compound that further slows gastric emptying
Journal of Clinical Medicine, 10 (16), 3644
The conclusion was that short-term treatment of chronic insomnia with DSIP is not likely to be of major therapeutic benefit
Adding to this are reports that acetaminophen products have been contaminated at various times, potentially increasing health risks
BPC-157 ist weder von der FDA noch der EMA fr die Anwendung am Menschen zugelassen
In addition, we proposed a pharmacological treatment algorithm for healthcare professionals, which could provide guidance in working toward an individualized pharmacological management of patients with IBS-D